Geeta Nagpal, MD
Interventional Pain Medicine · West Jordan, UTNPI 1386838183
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by GRT US Holding, Inc. at 33.3% of the total. Reporting peaked in 2022 at $5,468 and has fallen 52.2% since, to $2,612 in 2025.
Across 189 payments — averaging $57.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GRT US Holding, Inc.$4K
- Medtronic$2K
- Relievant Medsystems, Inc.$2K
- Spinal Simplicity, LLC$2K
- Abbott$864
- Boston Scientific$291
- plus $954 from 13 others
What the payments were for
- Consulting fees$3,20029%
- Travel & lodging$2,78526%
- Food & beverage$4,86845%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GRT US Holding, Inc. | 7 | $3,618 |
| Medtronic(2 entities) | 104 | $1,807 |
| Relievant Medsystems, Inc. | 10 | $1,794 |
| Spinal Simplicity, LLC | 11 | $1,524 |
| Abbott | 11 | $864 |
| Boston Scientific | 15 | $291 |
| Biotronik NRO, Inc. | 4 | $201 |
| Globus Medical | 8 | $171 |
| Stimwave Technologies Incorporated | 3 | $145 |
| Pacira Therapeutics, Inc. | 1 | $123 |
| Averitas Pharma Inc. | 5 | $104 |
| Nevro Corp. | 2 | $63 |
| Pfizer | 2 | $31 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Nalu Medical, Inc. | 1 | $21 |
| Painteq LLC | 1 | $19 |
| SPR Therapeutics, Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$3,421
- Intracept$3,222
- HA MINUTEMAN G3-R$1,397
- Proclaim IPG$430
- Proclaim DRG IPG$165
- SYNCHROMEDII$157
- INTELLIS$147
- Proclaim Family of SCS IPGs$142
- INTELLIS ADAPTIVESTIM$129
- Zilretta$123
- StimQ Receiver Stimulator Kit Channel A US w Receiver$113
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$113
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$113
- Freedom 4A Receiver Kit Channel A US w Receiver$113
- Freedom 8A Receiver Kit Channel A US w Receiver$113
How this compares
$10,853 in reported general payments places this provider in the 65th percentile of 26 interventional pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 11 | $8,060 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $4,276 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 176 | $3,387 |
| Buprenorphine | 21 | $2,772 |
| Gabapentin | 190 | $1,744 |
| Metaxalone | 11 | $1,512 |
| Fentanyl | 15 | $1,388 |
| Pregabalin | 65 | $959 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $728 |
| Diclofenac Sodium | 35 | $688 |
| Tramadol Hcl | 80 | $586 |
| Buprenorphine Hcl | 12 | $416 |
| Celecoxib | 15 | $263 |
| Duloxetine Hcl | 16 | $255 |
| Tizanidine Hcl | 41 | $246 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $22 | $8,06011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 26 interventional pain medicine providers in Utah.
Other interventional pain medicine in West Jordan
- Craig DavisWest Jordan$13K
- Ashleigh ByrneWest Jordan$11K
- Bryan HoelzerVineyard$718K
- Nathan ClementsSaint George$29K
- Rick ObraySt George$23K
- Brian RichardsonLogan$19K
- Alex NelsonMurray$17K
- Steven LarsenSaint George$14K
- J Riley StringhamProvo$13K
- Jie LuoSalt Lake City$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.